Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease

Journal of Renal Nutrition

Volumn 13, Issue 2, 2003, Pages 144-148

  Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ALBUMIN BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIALYSIS; DRUG EFFECT; ENDOTHELIUM LESION; HEART FAILURE; HEART INFARCTION; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LEUKOCYTE ACTIVATION; MALNUTRITION; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIDE EFFECT; STROKE; UREMIA; VASODILATATION; VITAMIN SUPPLEMENTATION;

EID: 0038375031     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/jren.2003.50018     Document Type: Conference Paper

References (22)

1. A Stenvinkel A Alvestrand Inflammation in end-stage renal disease: Sources, consequences and therapy Semin Dial 15 2002 330 338
2. BL Thurberg T Collins The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis Curr Opin Lipidol 9 1998 387 396
3. K Brand S Page G Rogler Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion J Clin Invest 97 1996 1715 1722
4. P Stenvinkel P Barany O Heimburger Mortality, malnutrition and atherosclerosis in end-stage renal disease: What is the role of interleukin-6? Kidney Int Suppl 80 2002 S103 S108
5. A Kato M Odamaki T Takita Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients Kidney Int 61 2002 1143 1152
6. P Stenvinkel O Heimbürger T Jogestrand Elevated interleukin-6 predicts progressive carotid atherosclerosis in dialysis patients: association to Chlamydia pneumoniae seropositivity Am J Kidney Dis 39 2002 274 282
7. M Girndt H Kaul U Sester Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events Kidney Int 62 2002 949 955
8. P Stenvinkel Endothelial dysfunction and inflammation—is there a link? Nephrol Dial Transpl 16 2001 1968 1971
9. C Zoccali FA Bendetto R Maas Asymmetric dimethylarginine, C-reactive protein, and carotid intima media thickness in end-stage renal disease J Am Soc Nephrol 13 2002 490 496
10. J Himmelfarb P Stenvinkel A Ikizler The elephant of uremia: Oxidative stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
11. M Annuk M Zilmer L Lind Oxidative stress and endothelial function in chronic renal failure J Am Soc Nephrol 12 2001 2747 2752
12. L Gullestad P Aukrust T Ueland Effect of high-versus low dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure J Am Coll Cardiol 34 1999 2061 2067
13. T Münzel JF Keaney Are ACE inhibitors a “magic bullet” against oxidative stress? Circulation 104 2001 1571 1574
14. HW Wilmink JD Banga M Hijmering Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function J Am Coll Cardiol 34 1999 140 145
15. JW Chang WS Yang WK Min Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients Am J Kidney Dis 39 2002 1213 1217
16. M Takemoto JK Liao Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arteioscler Thromb Vasc Biol 21 2001 1712 1719
17. MJ Mullen D Wright AE Donald Atorvastatin but not L-arginine improves endothelial function in type 1 diabetes mellitus. A double-blind study J Am Coll Cardiol 36 2000 410 416
18. SI Seliger NS Weiss DL Gillen HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients Kidney Int 61 2002 297 304
19. M Boaz S Smetana T Weinstein Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial Lancet 356 2000 1213 1218
20. S Devaraj I Jialal Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type-2 diabetic patients Free Rad Biol Med 29 2000 790 792
21. KN Islam D O'Byrne S Devaraj Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy Atherosclerosis 150 2000 217 224
22. RAP Skyrme-Jones RC O'Brien KL Berry Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: A randomized, placebo controlled study J Am Coll Cardiol 36 2000 94 102